Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.
about
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?Translational Research for Tuberculosis Elimination: Priorities, Challenges, and ActionsIssues Related to the Updated 2014 Korean Guidelines for TuberculosisMedical Management of Drug-Resistant TuberculosisDigital health for the End TB Strategy: developing priority products and making them work.Recent developments in the diagnosis and management of tuberculosis.Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow ImmunoassayNew anti-tuberculosis drugs and regimens: 2015 updateSputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings.An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients.Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China.The impact of novel tests for tuberculosis depends on the diagnostic cascade.Diagnostic value of GeneChip for detection of resistant Mycobacterium tuberculosis in patients with differing treatment historiesRifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort studyGlobal epidemiology of tuberculosis.Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled TrialOptimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisTuberculosis and rifampicin resistance among migrants in kyrgyzstan: detection by a new diagnostic test.The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get ThereRapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical SamplesRapid Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert Assay: A Clinical Study.Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces.Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya.Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.The multidrug-resistant tuberculosis threat: old problems and new solutionsLow implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco.Diagnostic Accuracy of Xpert Test in Tuberculosis Detection: A Systematic Review and Meta-analysis.Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.Rifampin drug resistance tests for tuberculosis: challenging the gold standard.Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patientsDiagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance.Performance of a lateral flow immunochromatography test for the rapid diagnosis of active tuberculosis in a large multicentre study in areas with different clinical settings and tuberculosis exposure levels.Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in NamibiaEffect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus.High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis.Evaluation of the Cepheid Xpert MTB/RIF assay.Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis.
P2860
Q26740240-685E4C2B-0A4E-4A23-9CE3-9F6C34FD848AQ26765051-0318CE56-27BA-4E36-8A8C-2F4370033DAAQ26771907-AB0E05D2-0051-4215-AF21-5223F1540839Q26801601-27B1BD1C-29C2-4329-AEDF-40FD55393FF9Q27321528-24021C6D-FA46-4208-A369-142672C38B31Q28077124-9688B05B-2DC8-4D6D-A127-635DBB2BB9C5Q28393235-E1BF06B8-9085-40EB-B53B-C935D2F8AF0CQ28547835-F9CB37EE-00E6-4C36-89F9-5CBA220961ADQ28596775-0366DBF3-4CF4-43DB-8663-C188118BE66CQ33754205-5D1BC947-A842-419E-A1AC-9487700D54FAQ33768767-304FF373-882B-4D46-BD73-2A73F8897352Q33793921-231DFF7E-600C-40AE-9AA6-0CA3E1E3BFBAQ34626498-F3760446-6C5F-47E2-AA85-71B843A19C5FQ34916301-2A5DF35A-1544-4C04-9BAF-F8A6D6D709B6Q34974157-BB4D5A16-62B8-49B6-835A-2D3DD633E99AQ35045088-140BB6EA-6D48-4CA4-94EE-F8A8316D96C3Q35071965-C76C7540-EF9E-4FC4-9FB9-5EBF59FB198DQ35075418-C1F3A5E4-E7FE-4052-BD51-7C1FB75C7275Q35181935-E7F2F840-EDED-422C-AEE9-464277D6A61FQ35662034-67CF52C6-288E-48DC-B8F1-C8BFB52BE800Q35757756-0D455561-51D8-4945-9F73-9BDE811132C9Q35792312-C6B4030D-9BE7-4FDD-81C6-384895812A93Q35890064-5A6EC581-9D15-43E2-8545-122A927BA47CQ35972660-B7C517E5-EBA8-40A9-B952-6B8EBD28C18DQ36084640-20939546-ABD7-4A87-80C6-8A2C8741D71BQ36138237-C0DB2183-616C-45E2-B490-211801749568Q36275494-5F8EE378-7E33-419D-AF3B-8FFCE221BD51Q36384233-5DED5B23-65F6-4B60-80F8-A27B4F525EF8Q36671821-750994B9-8843-4C2D-B72B-E40920157269Q36940706-FEFA411E-3817-4A0A-A191-58BD8B728FB3Q37036190-46FABB0D-359E-4F93-91E9-86E2CFB6CE4DQ37103951-BB631B93-AFAA-4AC7-8341-6C40887F7242Q37125148-5205623E-E84C-4662-9933-996530384F4CQ37528171-0C0073F2-7E36-4E47-8A19-19F0FB5B43BFQ37586825-46B1D69B-963C-491D-A2CB-5A818E5E455CQ37721301-E1F9EE28-2613-45C8-A264-7B8CF62F5408Q37733149-DF5F1A34-3B68-47D3-BF0D-7A7C93B05099Q38203355-8D01010D-D482-4495-A4CC-ED3C12511DA0Q38265418-36FE535C-0E0C-4282-9E90-31BF32B60296Q38341918-79556040-FEF4-4CF0-9DF2-84717D1DEB14
P2860
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rapid molecular TB diagnosis: ...... plementation of Xpert MTB/RIF.
@en
type
label
Rapid molecular TB diagnosis: ...... plementation of Xpert MTB/RIF.
@en
prefLabel
Rapid molecular TB diagnosis: ...... plementation of Xpert MTB/RIF.
@en
P2093
P50
P1476
Rapid molecular TB diagnosis: ...... plementation of Xpert MTB/RIF.
@en
P2093
Chris Gilpin
Daniela M Cirillo
Dennis Falzon
Jean de Dieu Iragena
Karin Weyer
Katherine Floyd
Lia D'Ambrosio
Matteo Zignol
P304
P356
10.1183/09031936.00157212
P577
2012-11-22T00:00:00Z